Moving away from ‘failed’ prednisone to IL-6 blockade in giant cell arteritis
Recent landmark study results have shown that interleukin-6 blockade may be superior to prolonged prednisone therapy in giant cell arteritis, according to a presenter at the 2020 Congress of Clinical Rheumatology-West.“The great majority of patients with GCA are unsuccessful in tapering their prednisone,” John H. Stone, MD, director of clinical rheumatology at Massachusetts General